LITHOCHOLATE SULFATION - A DETERMINANT OF HYPERTRANSAMINASEMIA IN CHENODEOXYCHOLATE-TREATED GALLSTONE PATIENTS

被引：0
|
作者：
SUE, SO
PEARLMAN, BJ
MARKS, JW
BONORRIS, GG
VARADY, P
LACHIN, JM
SCHOENFIELD, LJ
机构：
[1] CEDARS SINAI MED CTR,LOS ANGELES,CA 90048
[2] UNIV CALIF LOS ANGELES,LOS ANGELES,CA 90024
来源：
GASTROENTEROLOGY | 1980年 / 78卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1324 / 1324
页数：1
相关论文
共 50 条
  • [21] Tumor volume as outcome determinant in patients treated with chemoradiation for locally advanced esophageal cancer
    Crehange, Gilles
    Bosset, Mathieu
    Fabrice, Lorchel
    Buffet-Miny, Joelle
    Dumas, Jean Luc
    Mercier, Mariette
    Puyraveau, Marc
    Maingon, Philippe
    Bosset, Jean Francois
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2006, 29 (06): : 583 - 587
  • [22] Timing of aspirin administration as a determinant of survival of patients with acute myocardial infarction treated with thrombolysis
    Freimark, D
    Matetzky, S
    Leor, J
    Boyko, V
    Barbash, IM
    Behar, S
    Hod, H
    AMERICAN JOURNAL OF CARDIOLOGY, 2002, 89 (04): : 381 - 385
  • [23] Intensive rehabilitation as an independent determinant of better outcome in patients with lung tumors treated by thoracic surgery
    Glogowska, Oliwia
    Glogowski, Maciej
    Szmit, Sebastian
    ARCHIVES OF MEDICAL SCIENCE, 2017, 13 (06) : 1442 - 1448
  • [24] Age as a determinant of adverse events in medically treated cryptogenic stroke patients with patent foramen ovale
    Homma, S
    DiTullio, MR
    Sacco, RL
    Sciacca, RR
    Mohr, JP
    STROKE, 2004, 35 (09) : 2145 - 2149
  • [25] P53 mutation as a determinant of prognosis in GIST patients treated with imatinib mesylate.
    Ryu, MH
    Lee, H
    Kim, TW
    Chang, HM
    Lee, JL
    Kang, WK
    Bang, YJ
    Shin, DB
    Lee, KH
    Park, YH
    Kang, YK
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 820S - 820S
  • [26] THE EFFECT OF DIET ON BILE-ACID KINETICS AND BILIARY LIPID SECRETION IN GALLSTONE PATIENTS TREATED WITH URSODEOXYCHOLIC ACID
    FRENKIEL, PG
    LEE, DWT
    COHEN, H
    GILMORE, CJ
    RESSER, K
    BONORRIS, GG
    MARKS, JW
    SCHOENFIELD, LJ
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 1986, 43 (02): : 239 - 250
  • [27] SULFATION, O-METHYLATION, AND CLINICAL-RESPONSE IN PATIENTS WITH PARKINSONS-DISEASE TREATED WITH L-DOPA
    DOUSA, MK
    WEINSHILBOUM, RM
    MUENTER, MD
    TYCE, GM
    FEDERATION PROCEEDINGS, 1987, 46 (03) : 855 - 855
  • [28] Obtaining complete response is a major determinant of prolonged survival in patients treated for multiple myeloma relapsing with bortezomib
    Pascal, Laurent
    Leleu, Xavier
    HEMATOLOGIE, 2008, 14 (05): : 333 - 333
  • [29] Functional status as a determinant prognostic factor for overall survival in adult patients with medulloblastoma treated with chemotherapy and radiotherapy
    Ayala Alvarez, J. C.
    Trejo Rosales, R. R.
    Riera Salas, R.
    Chilaca Rosas, M. F.
    Rivera Rivera, S.
    Silva Godinez, J. C.
    Salvador Bonilla, B. A.
    ANNALS OF ONCOLOGY, 2019, 30
  • [30] Serum Troponin T as a Determinant of Drug-Induced Heart Failure Development in Patients Treated With Cyclophosphamide
    Kamiya, Kiwamu
    Nagai, Toshiyuki
    Komoriyama, Hirokazu
    Kato, Yoshiya
    Omote, Kazunori
    Aikawa, Tadao
    Noguchi, Keiji
    Tokuda, Yusuke
    Iwano, Hiroyuki
    Anzai, Toshihisa
    CIRCULATION, 2018, 138
12345